|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2007-10-8
|
|
pubmed:abstractText |
Esophageal resection (ER) remains the standard therapy for early esophageal cancer; however, because of concerns regarding high levels of morbidity and mortality reported in analyses of national databases, many patients are relegated to less effective endoscopic or chemotherapeutic approaches.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1091-255X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1395-402; discussion 1402
|
|
pubmed:meshHeading |
pubmed-meshheading:17763917-Adenocarcinoma,
pubmed-meshheading:17763917-Adult,
pubmed-meshheading:17763917-Aged,
pubmed-meshheading:17763917-Aged, 80 and over,
pubmed-meshheading:17763917-Barrett Esophagus,
pubmed-meshheading:17763917-Blood Loss, Surgical,
pubmed-meshheading:17763917-Carcinoma, Squamous Cell,
pubmed-meshheading:17763917-Critical Pathways,
pubmed-meshheading:17763917-Esophageal Neoplasms,
pubmed-meshheading:17763917-Esophagectomy,
pubmed-meshheading:17763917-Female,
pubmed-meshheading:17763917-Humans,
pubmed-meshheading:17763917-Length of Stay,
pubmed-meshheading:17763917-Male,
pubmed-meshheading:17763917-Middle Aged,
pubmed-meshheading:17763917-Neoadjuvant Therapy,
pubmed-meshheading:17763917-Neoplasm Staging,
pubmed-meshheading:17763917-Prognosis,
pubmed-meshheading:17763917-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer.
|
|
pubmed:affiliation |
Thoracic Oncology Program and Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA 98111, USA. gtsdel@vmmc.org
|
|
pubmed:publicationType |
Journal Article
|
